June 1, 2010
CASE CCC IN THE NEWS
Innovative Chemotherapy Delivery System Comes to Town
Cleveland State University Professor's Promising Cancer Research Hits an ...
Case CCC Scientific Retreat 2010: Thinking of Cancer as a Disease, Not a Cell Line
This retreat is an opportunity for the Center to identify the areas on which we should focus over the next two years in preparation for our renewal. Also, there will be many opportunities for interaction with your colleagues and fellow program members, including a working lunch and plenary program meetings planning sessions. Everyone is also invited to participate in special interest group discussions at dinner on Friday and breakfast on Saturday.
Another exciting addition to this year's agenda is a judged poster session featuring Cancer Center trainees, postdocs and fellows. This session will be a wonderful opportunity to become acquainted with the range of research being conducted in our members' laboratories, and to encourage our postdocs and students.
If you have not already done so, please RSVP for the retreat as soon as possible. Overnight rooms are filling up fast. As a reminder, overnight accommodations will be covered by the Cancer Center, but advance registration is required. We encourage you to stay and enjoy area attractions, such as Cedar Point, Sheldon Marsh Nature Preserve, wineries, the Lake Erie Islands, and Maritime Museums.
Cancer Center ACS IRG Pilot Funds
The RFA for the Cancer Center ACS IRG Pilot Grants to junior faculty investigators will be issued on or before Monday, June 7. These grants of up to $30,000 are awarded to provide seed money to foster cancer research by junior faculty who have no current national grant support of their own and are intended to support preliminary data to be used in seeking future and independently funded programs.
ASCO 2010 Annual Meeting
The Case CCC is pleased to have many members participating in the ASCO Annual Meeting, June 4-8 in Chicago. Click here to view a listing of Cancer Center participation. We encourage members who are attending the meeting to support their colleagues.
NEW FUNDING OPPORTUNITIES
Administrative Supplements to Advance Special Translational Research Acceleration Projects on Immune Response Modifiers Currently Funded by NCI
The NCI is accepting requests for administrative supplements to existing NCI funded grants of the following types: R01, P01, P30, P50, U01, U10, U19, or U54. This initiative is a part of the NCI Special Translational Research Acceleration Project (STRAP) Program. The overall purpose of the STRAP Program is to accelerate integrated research and development, including support of collaborative activities. A STRAP should take advantage of an opportunity to move translational research projects to the point of initiating clinical studies. Unique aspects of the STRAP Program are to support translational projects that would be delayed or are not easily done through the usual NCI funding mechanisms and to provide to these projects NCI resources that have been identified by the scientific community as critical to progress.
This administrative supplement funding opportunity (NOT-CA-10-025) from the STRAP Program is focused on the Immune Response Modifier (IRM) pathway. Any proposed activities to be supported by supplemental funding should be within the overall scope of the active parent NCI grant and interested investigators are encouraged to discuss eligibility with their grant Program Director.
Deadline: July 15
**All events are open to anyone interested in attending
Happy Memorial Day!
Department of Pathology Dissertation Defense
Hem/Onc Fellows Seminar canceled
Taussig Cancer Institute Grand Rounds canceled
Cancer Center Seminar Series/ Blood Club canceled
Cancer Center Research in Progress Seminar
For a complete listing of LRI seminars click here.
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ASCO Review 2010
Case CCC Scientific Retreat
Cancer Center Scientific Series
Cancer Center Scientific Series
ADDITIONAL UPCOMING SEMINARS & EVENTS
Business Education Course: "The Business of Regenerative Medicine: From Stem Cells to the Market Place"
Advanced Training Institute on Health Behavior Theory
International Symposium on Breast Cancer Prevention: Nutrition, Communication and Public Policy
ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer
Peer Reviewed Cancer Research Program (PRCRP)
The Fiscal Year 2010 (FY10) Defense Appropriation Act provides for $15 million (M) to the Department of Defense (DOD) Peer Reviewed Cancer Research Program (PRCRP) to research cancers not addressed in the breast, prostate, and ovarian cancer research programs currently executed by the DOD U. S. Army Medical Research and Materiel Command (USAMRMC).
Idea Awards support the exploration of ideas that are still in the early stages of development yet have the potential to yield high-impact results and open new avenues of investigation in the relevant topic areas. Proposals must not address breast, prostate, lung, or ovarian cancer research. Preliminary data is not required. Clinical Trials will not be supported. The maximum period of performance is 3 years. The maximum allowable direct cost amount for the entire period of performance is $375,000. In addition to direct costs, indirect costs may be proposed in accordance with the institution's negotiated rate agreement. Collaborative Option: Up to three investigators may collaborate on a single application, each of whom will be recognized as a principal investigator (PI) and receive a separate award. For multiple PIs, the combined total funding for all PIs from the entire period of performance may not exceed $750,000 in direct costs.
Translational New Investigator Awards support the development of translational research collaborations between an independent new investigator and a mentor to address at least one of the FY10 PRCRP Topic Areas in a manner relevant to military beneficiaries. Either the new investigator or the mentor must be a clinician. Proposal must not address breast, prostate, lung, or ovarian cancer research. Preliminary data are not required. Clinical trials will not be supported. Funding: The maximum period of performance is 3 years. The maximum allowable direct cost amount for the entire period of performance is $300,000. In addition to direct costs, indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
CTSC Pilot Funding for Comparative Effectiveness Research (CER) Infrastructure
The CTSC announces a new pilot competition for Comparative Effectiveness Research (CER) Infrastructure. Three pilots will be awarded at $50,000 each. The funding period is August 1, 2010 thru February 28, 2011.
The Lustgarten Foundation invites collaborative or individual applications proposing innovative approaches to target K-ras. Pancreatic cancers are one of the most lethal of all cancers and studies have found that up to 95% contain K-ras mutations. Therefore, the Foundation is prepared to allocate a significant portion of its multi-million dollar budget to a K-ras program.
MARK YOUR CALENDARS
Registration is now open for the Sixth Annual Oncology Congress, October 15-17 in San Francisco, CA.
This conference provides US-based, practicing oncologists, nurses and pharmacists with the latest clinical data and technology-driven innovations that directly enhance clinical practice and patient care.
At the conclusion of the Oncology Congress, participants will be better able to:
RACE FOR THE PLACE
Join Our Team
Come walk/run with us at the Race for the Place, an event to support the Gathering Place on Sunday, June 6 at Beachwood Place Mall. Registration opens at 7:30 am; race begins with the Survivor Ceremony at 9 am. Email email@example.com for more information.
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
Damon Runyon-Rachleff Innovation Award
Ovarian Cancer Research Fund Ovarian Cancer Research Training Programs of Excellence grant
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.